Virus | Page 89 of 96 | SpiritIndia.com

HIV :: Combination Microbicides Protect Against HIV-Like Virus

Experiments in female monkeys have for the first time shown that when used in combination, vaginal gels known as microbicides can protect against an HIV-like virus. The research, funded largely by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), suggests that similar combination microbicides could potentially provide a safe, effective and practical way to prevent HIV transmission to women, according to study investigators.

HIV :: Lamivudine – for use in pediatric patients with HIV

The Food and Drug Administration (FDA) announced the tentative approval of the drug product Lamivudine (la mi’ vyoo deen) Oral Solution, 10 mg/mL manufactured by Aurobindo Pharma LTD. of Hyderabad , India . Lamivudine Oral Solution is the first generic version of the already approved Epivir Oral Solution, 10 mg/mL, manufactured by GlaxoSmithKline. This child-friendly-product is indicated for use in pediatric patients with HIV from three months to 16 years, and will now be available for consideration for purchase under the President’s Emergency Plan for AIDS Relief.

HIV :: First rapid home testing kit for HIV

Authorities in the U.S. are considering the approval of the first rapid home testing kit for HIV.

Measles :: Information on Measles, Rubeola

Measles is a highly contagious viral illness characterized by a fever, cough, conjunctivitis (redness and irritation in membranes of the eyes), and spreading rash.

HIV :: Condoms – our most trusted method to prevent HIV infection and AIDS

These three words echo around the world . . . AIDS CRISIS WORSENS! – 40 million people infected worldwide – 37.2 million adults – 2.2 million children under 15.

HIV :: FDA approves generic zidovudine oral solution

FDA announced the tentative approval of zidovudine oral solution, a generic version of a child-friendly oral solution to help keep AIDS virus from reproducing.

Influenza :: New Influenza Vaccine for Upcoming Flu Season

The Food and Drug Administration (FDA) approved Fluarix, an influenza vaccine for adults that contains inactivated virus. Fluarix is approved to immunize adults 18 years of age and older against influenza virus types A and B contained in the vaccine. Influenza is also commonly called the flu.

Heart Disease :: Stem cells fight heart disease in mice

A team of researchers, led by Roger Davis of the San Diego State University Heart Institute, has executed a war plan from Greek mythology to help grab the upper hand in the fight against heart disease.

Hepatitis :: Expanded program of hepatitis A vaccination of children

Following implementation of an expanded program of hepatitis A vaccination of children, the overall hepatitis A rate in the U.S. has declined by 76 percent, according to a study in the July 13 issue of JAMA.

HIV :: Confusion and Conflict when it comes to HIV and AIDS

In Canada, HIV was first diagnosed among gay men. Later, hemophiliacs and others with health problems were infected due to tainted blood received through blood transfusions. People infected early on had no treatment available! A new and strange virus was weakening the immune system and causing illness in various ways, (what we now know as opportunistic. infections). That?s all we knew! Those who were infected looked for ways to boost their immune system. Not everyone affected by the disease was dying. Unfortunately, the media wrote only about those who were being ravaged by the disease and dying.